Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Power3 Medical Products Inc. Publishes Discovery of Protein Biomarkers for Esophageal Malignancies in the International Journal of Cancer
March 25th, 2008
Power3 Medical Products, Inc. (OTCBB:PWRM, https://www.power3medical.com), a leading proteomics company specializing in the development and commercialization of diagnostic tests for the early detection of breast cancer and neurodegenerative diseases, has published the discovery of protein biomarkers for esophageal malignancies in the International Journal of Cancer. The article, titled "Alterations in Barrett's-related adenocarcinomas: A proteomic approach," was co-authored by Dr. Essam A. Sheta, Director of Biochemistry, and Dr. Ira L. Goldknopf, Director of Proteomics at Power3. Dr. Sheta and Dr. Goldknopf worked in collaboration with Dr. Wael El-Rifai, MD, PhD,...
Source: Cancer Weekly (2008-03-25)
|
